PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2092736
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2092736
Malaria Diagnostics market size was valued at US$ 760.5 Million in 2025, expanding at a CAGR of 2.8% from 2026 to 2033.
Diagnosis of malaria requires both clinical and parasitological means of detection to manage malaria properly. The microscopy Testing Location involves the use of thin and thick blood films using a light microscope and has traditionally been used for the diagnosis of malaria. This is because it has been traditionally used in the diagnosis of malaria. The HRP-2 and pLDH antigen test is widely used in the diagnosis of malaria. These integrated diagnostic approaches enable timely, accurate malaria detection, supporting effective treatment and disease control.
Malaria Diagnostics Market- Market Dynamics
Increasing Emphasis on Early Malaria Diagnosis to Drive Market Growth
Growing emphasis on malaria diagnosis is considered one of the key elements influencing the malaria diagnostics market, owing to the growing need for prompt detection, speedy treatment, and disease monitoring that help reduce the morbidity and mortality caused by malaria infection. For instance, in 2026, as per APMEN Org, China continues to be declared as being malaria-free due to its sophisticated early detection and disease monitoring system with the adoption of the "1-3-7" strategy, where infections are notified in one day, investigated in three days, and then actions are taken against them within seven days. This proactive approach strengthens malaria control efforts and accelerates progress towards elimination.
The Global Malaria Diagnostics market is segmented on the basis of Technology, Sample Type, Testing Location, End Use, and Region.
Under technology, rapid diagnostic tests (RDTs) play a key role because the application of RDTs is quite wide regarding the quick and efficient detection of malaria in situ at an affordable price in the resource-constrained setting. For instance, in 2026, as per reports by the World Health Organization (WHO), the use of WHO-recommended Rapid Diagnostic Tests (WRDs) continues to increase in relation to disease surveillance and diagnosis. Data through rapid molecular diagnostic tests have been collected as the most up-to-date information on them. This increasing trend has highlighted the significance of rapid diagnostic tests for malaria control around the globe.
Malaria Diagnostics Market- Geographical Insights
The North American Malaria Diagnostics market is motivated by surveillance, screening, and an already existing laboratory infrastructure that ensures accurate diagnosis of imported cases of malaria. For instance, in 2025-2026, according to the American Clinical Laboratory Association (ACLA), clinical labs in the USA are responsible for contributing over USD 140,000 million in value to the economy of the country, which constitutes around 0.46% of the GDP of the USA. Furthermore, the industry creates almost 668,000-670,000 jobs in the country, creating around USD 56,000 million worth of salary and also adding over USD 19,000 million in taxes to state and federal governments. The established system of diagnostics will further improve malaria detection and surveillance in North America.
Nigeria Malaria Diagnostics Market- Country Insights
Nigeria had a considerable contribution to the African Malaria Diagnostics market as a result of its high malaria prevalence and persistent efforts in enhancing malaria diagnosis. Government-led malaria control programs, international partnerships, and the rising popularity of rapid diagnostic tests (RDTs), especially in underprivileged and rural areas. For instance, according to the Severe Malaria Observatory and Nigeria's National Malaria Elimination Programme (NMEP), Nigeria accounts for 27% of the total number of malaria cases globally and 31% of all the malaria deaths. The government, through NMEP, develops different interventions, including the distribution of mosquito nets treated with insecticides, rapid diagnostic tests, malaria chemoprevention, and case management. These sustained initiatives continue to strengthen malaria diagnosis, improve treatment access, and reduce disease burden.
The competitive structure of the malaria diagnosis industry will be determined by the entry of companies like Abbott, bioMerieux, Beckman Coulter Inc., Siemens Healthineers, and Bio-Rad Laboratories, Inc. into the market. Some of the business strategies that have been used by the companies to develop their presence in the market so as to cope with the demands of the changing diagnostic needs of healthcare providers include Sample Type development, collaboration, mergers and acquisitions, and geographical expansion. bioMerieux has entered into an asset acquisition agreement with Day Zero Diagnostics in June 2025 and has upgraded its next-generation Sample Types for the diagnosis of infectious diseases through genomic sequencing and machine learning. These strategic initiatives are expected to accelerate innovation and strengthen competitive positioning across the malaria diagnostics market.
In March 2026, Premier Medical Corporation Pvt. Ltd. launched the First Response(R) Malaria Ag. P.f. (HRP2)/P.f. (pLDH)/P.v. (pLDH) Test, expanding its malaria rapid diagnostic portfolio with a multi-antigen assay designed to improve detection of Plasmodium falciparum and Plasmodium vivax.
SCOPE OF THE REPORT